Menu

Generic Harvoni (HEPCINAT-LP)_Natco

 

Generic Name:SOFOSBUVIR+LEDIPASVIR
Indian Brand Name:HEPCINAT-LP
Manufacturer:Natco Pharma Ltd.
Strength:SOFOSBUVIR 400mg+LEDIPASVIR 90mg
Packaging:Bottle of 28 Tablets

 

$330.00

  • CNY: ¥2,227.50

Description

HEPCINAT-LP contains polymerase inhibitors which called sofosbuvir and ledipasvir . Hepcinat-LP launched by Natco Pharma Ltd (India) and approved for treatment patients infected with HCV genotypes 1 and 4. Sofosbuvir & Ledipasvir is FDA-approved and EASL recommended treatment protocol for HCV, which does not include interferon or ribavirin.  Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.

Never Treated for Hep C

Ledipasvir + sofosbuvirTypeWeeks of TreatmentCure Rate
Ia12 weeks96%
Ib12 weeks98%

Previously Treated for Hep C

Ledipasvir + sofosbuvirTypeCure Rate for 12 weeksCure Rate for 24 weeks
Ia95%99%
Ib87%100%
Cirrhosis86%100%
No Cirrhosis86%99%
Ever Treated for Sofosbuvir, peginterferon alfa, and ribavirin, but failed93%100%

 

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.